+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Secukinumab"

Psoriasis Drugs Market - Growth, Trends, and Forecast (2020 - 2025) - Product Thumbnail Image

Psoriasis Drugs Market - Growth, Trends, and Forecast (2020 - 2025)

  • Report
  • May 2020
  • 111 Pages
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
From
Cutaneous Lupus Erythematosus (CLE) - Market Insights, Epidemiology and Market Forecast - 2028 - Product Thumbnail Image

Cutaneous Lupus Erythematosus (CLE) - Market Insights, Epidemiology and Market Forecast - 2028

  • Drug Pipelines
  • July 2019
  • 191 Pages
From
Autoimmune Disease Therapeutics Market by Drug Class, Indication and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 - Product Thumbnail Image

Autoimmune Disease Therapeutics Market by Drug Class, Indication and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • Report
  • February 2019
  • 202 Pages
From
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry - Product Thumbnail Image

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

  • Report
  • January 2019
  • 180 Pages
From
Competitor Landscape: Spondyloarthritis - Product Thumbnail Image

Competitor Landscape: Spondyloarthritis

  • Report
  • November 2018
  • 64 Pages
From
Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022

  • Report
  • September 2018
  • 115 Pages
From
Psoriatic Arthritis Market and Forecast Analysis 2035 - Product Thumbnail Image

Psoriatic Arthritis Market and Forecast Analysis 2035

  • Drug Pipelines
  • July 2018
  • 503 Pages
From
Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

  • Report
  • June 2018
  • 52 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • June 2018
  • 125 Pages
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • 1052 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • March 2018
  • 181 Pages
From
Psoriasis Drugs Market Analysis by Therapeutic Class (Tumor Necrosis Factor-inhibitors, Interleukin-inhibitors, Vitamin D analogues), by Treatment (Topicals, Systemic, Biologics) And Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Psoriasis Drugs Market Analysis by Therapeutic Class (Tumor Necrosis Factor-inhibitors, Interleukin-inhibitors, Vitamin D analogues), by Treatment (Topicals, Systemic, Biologics) And Segment Forecasts, 2016 - 2022

  • Report
  • November 2017
  • 171 Pages
From
US Market Overview for Immunology Drugs 2018 - MedView - Product Thumbnail Image

US Market Overview for Immunology Drugs 2018 - MedView

  • Report
  • October 2017
  • 938 Pages
From
US Market Report for Psoriasis Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Psoriasis Immunology Drugs 2018 - MedCore

  • Report
  • October 2017
  • 930 Pages
From
US Market Report for Rheumatoid Arthritis Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Rheumatoid Arthritis Immunology Drugs 2018 - MedCore

  • Report
  • October 2017
  • 928 Pages
From
US Market Report for Ulcerative Colitis Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Ulcerative Colitis Immunology Drugs 2018 - MedCore

  • Report
  • October 2017
  • 928 Pages
From
US Market Report for Crohn's Disease Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Crohn's Disease Immunology Drugs 2018 - MedCore

  • Report
  • October 2017
  • 929 Pages
From
US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - MedCore - Product Thumbnail Image

US Market Report for Ankylosing Spondylitis Immunology Drugs 2018 - MedCore

  • Report
  • October 2017
  • 928 Pages
From
US Market Product Portfolio for Immunology Drugs 2018 - MedFolio - Product Thumbnail Image

US Market Product Portfolio for Immunology Drugs 2018 - MedFolio

  • Report
  • October 2017
  • 987 Pages
From
Loading Indicator
adroll